Assignee
Xyra LLC
US·6 granted patents·3 pending applications·9 citations·filing 2022–2025
Top patents by PatentIndex Score
9 records- 0195US11759640B2Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2022·Granted Sep 19, 2023·5 cites·13 claims
- 0293US11975202B2Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2023·Granted May 7, 2024·2 cites·20 claims
- 0392US2026091235A1Methods for Reducing the Risk of Heart Failure or Strokes by Pharmacotherapy to Reduce Atrial FibrillationsXyra LLC·Filed 2025·Application pending·0 cites
- 0491US12257228B2Cardioversion methods using budiodaroneXyra LLC·Filed 2023·Granted Mar 25, 2025·1 cites·24 claims
- 0591US12115373B2Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2023·Granted Oct 15, 2024·1 cites·20 claims
- 0684US12551706B2Methods for reducing the risk of heart failure or strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2024·Granted Feb 17, 2026·0 cites·20 claims
- 0779US11839768B2Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillationsXyra LLC·Filed 2023·Granted Dec 12, 2023·0 cites·38 claims
- 0863US2023372284A1Methods for treating atrial fibrillationsXyra LLC·Filed 2023·Application pending·0 cites
- 0960US2025281448A1Cardioversion Methods Using BudiodaroneXyra LLC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →